Hot Pursuit     30-May-24
Zydus Lifesciences Ltd slips for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 1024.9, down 1.9% on the day as on 13:19 IST on the NSE. The stock jumped 104.04% in last one year as compared to a 21.68% rally in NIFTY and a 50.2% spurt in the Nifty Pharma index.

Zydus Lifesciences Ltd is down for a fifth straight session today. The stock is quoting at Rs 1024.9, down 1.9% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 22553.1. The Sensex is at 74074.04, down 0.58%.Zydus Lifesciences Ltd has added around 3.73% in last one month.Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has eased around 0.42% in last one month and is currently quoting at 19321.35, down 1.44% on the day. The volume in the stock stood at 9.12 lakh shares today, compared to the daily average of 18.39 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 1026.7, down 2.05% on the day. Zydus Lifesciences Ltd jumped 104.04% in last one year as compared to a 21.68% rally in NIFTY and a 50.2% spurt in the Nifty Pharma index.

The PE of the stock is 30.5 based on TTM earnings ending March 24.

Previous News
  Zydus Lifesciences' injectable manufacturing site concludes USFDA inspection
 ( Corporate News - 24-Apr-24   09:49 )
  Zydus Lifesciences consolidated net profit rises 109.70% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   17:49 )
  Board of Zydus Lifesciences recommends Final Dividend
 ( Corporate News - 17-May-24   16:18 )
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus Life gains on USFDA nod for prostatic hyperplasia drug
 ( Hot Pursuit - 18-Mar-24   09:40 )
  Stocks in focus: Ajanta Pharma, Zydus Lifesciences, HAL, L&T, Deccan Gold Mines
 ( Market Commentary - Stock Alert 08-Mar-23   08:32 )
  Zydus Lifesciences to hold AGM
 ( Corporate News - 17-May-24   17:45 )
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Zydus Life receives EIR from USFDA for Ahmedabad facility
 ( Hot Pursuit - 03-Jul-23   11:22 )
  Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:29 )
  Zydus Lifesciences appoints director
 ( Corporate News - 17-May-24   15:47 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top